Contineum shares fell 9.9% due to the failure of mid-term clinical trials of an antidepressant developed in collaboration with Johnson & Johnson.

Zhitongcaijing · 1d ago
Contineum shares fell 9.9% due to the failure of mid-term clinical trials of an antidepressant developed in collaboration with Johnson & Johnson.